文献速递气道管理术前评估与围术期医学

无呼吸患者高流量鼻氧疗期间二氧化碳变化:单中心随机对照非劣效性试验

Carbon Dioxide Changes during High-flow Nasal Oxygenation in Apneic Patients: A Single-center Randomized Controlled Noninferiority Trial.
PubMed 文献 · Anesthesiology · 2022-01-01

该单中心随机对照非劣效性试验纳入125例择期麻醉肌松成年手术患者,比较五种不同流量100%氧气在15分钟无呼吸期间动脉血二氧化碳分压线性上升率。结果显示各流量组与对照组相比均达到非劣效性(预设界值0.3 mmHg·min⁻¹),不支持高流量鼻氧疗具有额外通气效应。

要点

  • 不同流量100%氧气无呼吸期间PaCO₂上升率相似,高流量鼻氧无额外通气效应。
  • 各流量组与对照组差值均达非劣效性,95%CI上限未超过0.3 mmHg·min⁻¹。
  • 临床应关注无呼吸期间二氧化碳蓄积,不应依赖高流量鼻氧通气。

核心结论

  • 广泛不同的湿化100%氧气流量在无呼吸期间导致相当的动脉血二氧化碳分压上升,不支持高流量鼻氧疗具有额外通气效应。

研究设计与样本

  • 单中心随机对照非劣效性试验,125例择期麻醉肌松成年手术患者随机分为五组,每组25例,15分钟无呼吸期间每2分钟行动脉血气分析。

主要发现

  • 高流量组与对照组PaCO₂线性上升率差值均值-0.0 mmHg·min⁻¹(95%CI -0.3, 0.3,非劣效性P=0.030)。
  • 中流量组与对照组差值-0.1 mmHg·min⁻¹(95%CI -0.4, 0.2,P=0.002)。
  • 低流量组与对照组差值-0.1 mmHg·min⁻¹(95%CI -0.4, 0.2,P=0.003)。
  • 最小流量组与对照组差值-0.1 mmHg·min⁻¹(95%CI -0.4, 0.2,P=0.004)。

关键数值与推荐

  • 预设非劣效性界值为0.3 mmHg·min⁻¹。
  • 终止标准包括SpO₂<92%、经皮二氧化碳>100 mmHg、pH<7.1、钾>6 mmol·l⁻¹或无呼吸时间达15分钟。

临床怎么用

  • 无呼吸期间即使使用高流量鼻氧,仍需监测二氧化碳蓄积,不应假定其提供通气。
  • 各流量下PaCO₂上升率相当,临床选择氧流量时应主要考虑氧合而非通气。

局限性

  • 单中心研究,样本量有限(每组25例),仅限择期麻醉肌松成年手术患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anesthesia studies using high-flow, humidified, heated oxygen delivered via nasal cannulas at flow rates of more than 50 l · min-1 postulated a ventilatory effect because carbon dioxide increased at lower levels as reported earlier. This study investigated the increase of arterial partial pressure of carbon dioxide between different flow rates of 100% oxygen in elective anesthetized and paralyzed surgical adults before intubation. METHODS: After preoxygenation and standardized anesthesia induction with nondepolarizing neuromuscular blockade, all patients received 100% oxygen (via high-flow nasal oxygenation system or circuit of the anesthesia machine), and continuous jaw thrust/laryngoscopy was applied throughout the 15-min period. In this single-center noninferiority trial, 25 patients each, were randomized to five groups: (1) minimal flow: 0.25 l · min-1, endotracheal tube; (2) low flow: 2 l · min-1, continuous jaw thrust; (3) medium flow: 10 l · min-1, continuous jaw thrust; (4) high flow: 70 l · min-1, continuous jaw thrust; and (5) control: 70 l · min-1, continuous laryngoscopy. Immediately after anesthesia induction, the 15-min apnea period started with oxygen delivered according to the randomized flow rate. Serial arterial blood gas analyses were drawn every 2 min. The study was terminated if either oxygen saturation measured by pulse oximetry was less than 92%, transcutaneous carbon dioxide was greater than 100 mmHg, pH was less than 7.1, potassium level was greater than 6 mmol · l-1, or apnea time was 15 min. The primary outcome was the linear rate of mean increase of arterial carbon dioxide during the 15-min apnea period computed from linear regressions. RESULTS: In total, 125 patients completed the study. Noninferiority with a predefined noninferiority margin of 0.3 mmHg · min-1 could be declared for all treatments with the following mean and 95% CI for the mean differences in the linear rate of arterial partial pressure of carbon dioxide with associated P values regarding noninferiority: high flow versus control, -0.0 mmHg · min-1 (-0.3, 0.3 mmHg · min-1, P = 0.030); medium flow versus control, -0.1 mmHg · min-1 (-0.4, 0.2 mmHg · min-1, P = 0.002); low flow versus control, -0.1 mmHg · min-1 (-0.4, 0.2 mmHg · min-1, P = 0.003); and minimal flow versus control, -0.1 mmHg · min-1 (-0.4, 0.2 mmHg · min-1, P = 0.004). CONCLUSIONS: Widely differing flow rates of humidified 100% oxygen during apnea resulted in comparable increases of arterial partial pressure of carbon dioxide, which does not support an additional ventilatory effect of high-flow nasal oxygenation.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Riva T, Greif R, Kaiser H, et al. Carbon Dioxide Changes during High-flow Nasal Oxygenation in Apneic Patients: A Single-center Randomized Controlled Noninferiority Trial. Anesthesiology. 2022. PMID: 34758057. doi:10.1097/ALN.0000000000004025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。